Patent application number | Description | Published |
20100087439 | NOVEL PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN - The present invention relates to an agent for preventing and/or treating neuropathic pain comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating neuropathic pain, and particularly useful for providing an agent for preventing and/or treating allodynia, hyperalgesia, hyperesthesia, spontaneous pain, cancer pain, trigeminal neuralgia, phantom limb pain, postherpetic neuralgia, fibromyalgia, low back/leg pain, thalamic pain, entrapment (compressive) peripheral neuropathy, atypical facial pain, pain accompanying spinal cord injury, pain accompanying multiple sclerosis, pain accompanying chemotherapy-induced neuropathy, cancer pain on which an analgesic effect of a narcotic analgesic such as morphine is insufficient, pain accompanying diabetic neuropathy, and the like. | 04-08-2010 |
20100113451 | NOVEL PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DIABETIC NEUROPATHY - The present invention relates to an agent for preventing and/or treating diabetic neuropathy comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating diabetic neuropathy, and particularly useful for providing an agent for preventing and/or treating diabetic motor neuropathy (such as muscle weakness disorder (such as muscle weakness disorder with inability to walk independently)), diabetic sensory neuropathy (such as paresthesia (such as vibration perception abnormality), allodynia, hypoesthesia (such as numbness of extremities or cold sensation), or pain), or diabetic autonomic neuropathy (such as stool abnormality (such as constipation or diarrhea), urination disorder, impotence, orthostatic hypotension, sudomotor dysfunction, abnormal heart rate variability, or delayed gastric emptying). Further, the invention is particularly useful for providing an agent for improving pathophysiology of diabetic neuropathy. | 05-06-2010 |
20110144947 | Online Diagnostic Method and Online Diagnostic System for Geothermal Generation Facility - An online diagnostic system for a geothermal generation facility is discloses that includes: an automatic steam measurement device for measuring a characteristic of steam to be supplied to a steam turbine from a steam-water separator at the geothermal generation facility that outputs analysis data. A monitor•control device controls an operation of the geothermal generation facility while monitoring the geothermal generation facility. A diagnostic device performs at least one of an evaluation of a steam characteristic at the geothermal generation facility, an evaluation of the steam-water separator, and an evaluation of pulsation and confluence of a production well based on the analysis data from the automatic steam measurement device and performance data of the geothermal generation facility from the monitor•control device. An operating status of the geothermal generation facility is diagnosed. | 06-16-2011 |
20110152268 | NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NOCICEPTIVE PAIN - The present invention relates to a pharmaceutical composition for treating nociceptive pain, containing a morpholine derivative or a pharmaceutically acceptable salt thereof, as an active ingredient. The present invention is useful in providing an excellent pharmaceutical composition for treating nociceptive pain. In addition, the present invention is particularly useful in providing a pharmaceutical composition for treating pain accompanying a disease selected from the group consisting of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, spondylosis deformans, gouty arthritis, juvenile arthritis, scapulohumeral periarthritis, and cervical syndrome, lumbago, lumbago accompanying spondylosis deformans, menalgia, pain and tumentia after inflammation, operation or injury, pain after odontectomy, and cancer pain. In addition, the present invention is particularly useful for alleviating pain in a damaged cartilage region, and is particularly useful for osteoarthritis in which NSAIDs are not effective. | 06-23-2011 |
20110239649 | Steam Characteristics Automatic Measuring Device and Geothermal Power-Generating Device - Provided is a steam characteristics automatic measuring device capable of automatically, ideally also continuously measuring the characteristics of steam taken from a production well, without being affected by interfering components, such as hydrogen sulfide gas and carbon dioxide gas contained in large quantities in steam taken from under the ground, which enables the operator to continuously understand the characteristics of steam and support a smooth operation of a geothermal power plant. The device has a silica monitor for measuring a concentration of silica included in a condensate obtained by cooling steam taken from under the ground; an electrical conductivity meter for automatically measuring the electrical conductivity thereof; a pH meter for automatically measuring the pH value thereof; and a data processing transmitter for automatically transmitting data measured by each of the monitor and meters. A geothermal power-generating device equipped with the steam characteristics automatic measuring device is also provided. | 10-06-2011 |
20130023535 | METHOD OF PREVENTING AND/OR TREATING DIABETIC NEUROPATHY - The present invention relates to an agent for preventing and/or treating diabetic neuropathy comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating diabetic neuropathy, and particularly useful for providing an agent for preventing and/or treating diabetic motor neuropathy (such as muscle weakness disorder (such as muscle weakness disorder with inability to walk independently)), diabetic sensory neuropathy (such as paresthesia (such as vibration perception abnormality), allodynia, hypoesthesia (such as numbness of extremities or cold sensation), or pain), or diabetic autonomic neuropathy (such as stool abnormality (such as constipation or diarrhea), urination disorder, impotence, orthostatic hypotension, sudomotor dysfunction, abnormal heart rate variability, or delayed gastric emptying). Further, the invention is particularly useful for providing an agent for improving pathophysiology of diabetic neuropathy. | 01-24-2013 |
Patent application number | Description | Published |
20080232166 | CONTENT DATA STORAGE DEVICE AND ITS CONTROL METHOD - A content data storage device which stores content data in nonvolatile memories from which data is erasable in units of blocks includes a bus width conversion unit converting a transmission bus to buses of a plurality of systems, a storage unit including a plurality of sets of memories, a plurality of switching units selectively switching between derivation of the content data and derivation of command signals and addresses, a controller configuring to perform (i) conversion control, (ii) state control, (iii) supply control, and (iv) switching control, the controller controlling the operation for reading and writing the content data with reference to the nonvolatile memories, and, a plurality of switch on and off units selectively switching on or off the content data, the command signals and the addresses. | 09-25-2008 |
20080232175 | CONTENT DATA STORAGE DEVICE AND ITS CONTROL METHOD - A content data storage device which stores content data which includes a wide-band content and a narrow-band content includes a buffer memory temporarily storing the content data to be externally input, a storage unit including a plurality of nonvolatile memories configured to be written for each page and storing in turn the content data to be output from the buffer memory, and a controller controlling an output from the buffer memory so as to output content data of one page to the storage unit when the content data of not less than one page is stored in the buffer memory, wherein the controller adds dummy data to the narrow-band content as the content data of one page, if the narrow-band content stored in the buffer memory reaches the prescribed capacity. | 09-25-2008 |
20090138783 | CONTENT DATA RECORDING APPARATUS AND METHOD - A content data recording apparatus includes a code addition unit adding an error correction code to an input content data, a data storing unit temporarily storing the content data, and outputting it, a plurality of nonvolatile memories that enable writing/reading of the content data, a generator generating a write address and a read address, a read buffer temporarily storing the read content data, and outputting it, an error correction unit correcting an error of the content data based on the error correction code, and giving correction impossible notification when the error is not corrected by the error correction code, and a controller carrying out a read control for reading content data from the nonvolatile memories, and carrying out a first rewrite control for controlling the data storing unit so that the data storing unit again outputs content data, and writing the content data again output to the nonvolatile memories. | 05-28-2009 |